PRESS RELEASE published on 01/23/2025 at 06:45, 1 year 3 months ago Galenica enregistre une nouvelle fois une forte croissance du chiffre d’affaires Galenica enregistre une nouvelle fois une forte croissance du chiffre d’affaires avec une évolution de 4,7% en 2024, dépassant ainsi le marché pharmaceutique suisse Chiffre D'affaires Croissance Perspectives Galenica Pharmaceutique
PRESS RELEASE published on 01/23/2025 at 06:45, 1 year 3 months ago Galenica reports strong sales growth once again Galenica reports strong sales growth once again in 2024, outperforming pharmaceutical market. Guidance for 2024 annual results confirmed, projecting EBIT growth between 8%-11% Sales Growth EBIT Growth Galenica Pharmaceutical Market 2024 Results
BRIEF published on 10/24/2024 at 06:50, 1 year 6 months ago Galenica Reports Robust Sales Growth in Third Quarter Sales Growth Pharmaceutical Market Galenica AG Generics And Biosimilars Logistics & IT
BRIEF published on 10/24/2024 at 06:50, 1 year 6 months ago Galenica annonce une forte croissance de son chiffre d'affaires au troisième trimestre Croissance Des Ventes Marché Pharmaceutique Galenica SA Génériques Et Biosimilaires Logistique Et Informatique
PRESS RELEASE published on 10/24/2024 at 06:45, 1 year 6 months ago Galenica increases sales growth in the third quarter Galenica reports 4.1% sales growth in the third quarter of 2024, outperforming the pharmaceutical market. Confirms sales growth outlook for 2024 2024 Outlook Sales Growth Galenica Pharmaceutical Market Third Quarter
PRESS RELEASE published on 10/24/2024 at 06:45, 1 year 6 months ago Galenica augmente la croissance du chiffre d’affaires au troisième trimestre Galenica a augmenté son chiffre d'affaires de 4.1% au troisième trimestre 2024, dépassant la croissance du marché pharmaceutique suisse. Perspectives 2024 confirmées avec une croissance du CA entre 3% et 5% Chiffre D'affaires Croissance Galenica Pharmaceutique Trimestriel
BRIEF published on 08/06/2024 at 07:05, 1 year 9 months ago Élargissement de la Direction et passage de témoin au poste de CFO chez Galenica Stratégie CFO Reorganisation Galenica Pharmacies
BRIEF published on 08/06/2024 at 07:05, 1 year 9 months ago Expansion of management and handover to the position of CFO at Galenica CFO Reorganization Strategy Galenica Pharmacies
PRESS RELEASE published on 08/06/2024 at 07:00, 1 year 9 months ago Élargissement de la Direction et passage de témoin au poste de CFO Galenica AG réoriente ses pharmacies vers une approche client; Stephan Mignot rejoint la Direction pour le marketing. Fusion de 'Products & Brands' et 'Home Care'. Changement de CFO. Croissance stratégique CFO Marketing Croissance Stratégique Galenica AG Pharmacies
PRESS RELEASE published on 08/06/2024 at 07:00, 1 year 9 months ago Expansion of the Executive Committee and handover of the position of CFO Galenica restructures its executive team to enhance customer focus. CFO Felix Burkhard to step down by end of 2024, Julian Fiessinger to take over. Strategic aims include growth and improved customer satisfaction CFO Restructuring Growth Galenica Customer Focus
Published on 05/08/2026 at 15:55, 21 minutes ago Class 1 Nickel and Technologies Ltd. Announces Private Placement and Share for Debt Offering
Published on 05/08/2026 at 15:00, 1 hour 16 minutes ago Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule
Published on 05/08/2026 at 14:55, 1 hour 21 minutes ago Nepra Foods Inc. to Present at the 16th Annual LD Micro Invitational
Published on 05/08/2026 at 14:30, 1 hour 46 minutes ago Unusual Machines Hosts Live Drone Ecosystem Demonstrations at XPONENTIAL 2026
Published on 05/08/2026 at 14:00, 2 hours 16 minutes ago BlackBerry Announces Renewal of Normal Course Issuer Bid Share Buyback Program
Published on 05/08/2026 at 16:05, 10 minutes ago ANTHBOT Announces Marc ter Stegen as Global Brand Ambassador
Published on 05/08/2026 at 15:32, 43 minutes ago EQS-Adhoc: The Management Board and Supervisory Board of 11880 Solutions AG approve a proposal for a 5:1 share capital reduction
Published on 05/08/2026 at 15:26, 49 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 05/07/2026 at 19:15, 21 hours 1 minute ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 21 hours 1 minute ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 21 hours 10 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 21 hours 10 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 21 hours 16 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
